Efectivity of intratympanic corticosteroids in the treatment of Meniere´s disease- Cohort study.
Abstract Introduction and objective: Meniere´s disease (MD) is a chronic auditory pathology characterized by the presence of hearing loss, episodic dizziness and tinnitus. To value the hearing improvement and the reduction of vertiginous crises in patients with Meniere´s disease after the administration of intratympanic corticosteroids. Method: Retrospective cohort study of a sample of 55 patients diagnosed with definitive Meniere´s disease and treated with intratympanic corticosteroids (ITS). Results: Of the 39 patients who were treated with ITS for vertigo attacks, one month into the treatment, 27 had no attacks, 11 experienced a few (<5) and only 1 had several attacks (5-10). Six months after the first injection, 19 had no seizures, 13 reported a few, 5 had several, and 2 manifested numerous attacks (> 10). There were 16 patients treated with ITS for hearing loss and they reflected a mean hearing loss of 46.61 dB prior to the treatment. One month after the injection, the mean loss was 42.77 dB (1.84) and at six months it was 41.66 dB (2.95). Discussion: The audiometric benefit obtained is ?3 dB after ITS, other authors in their studies have obtained results similar to ours, of 3.3 dB and 2.3dB. A clear decrease in the number of vertiginous crises is reflected after the ITS, several authors reach our same conclusion. Conclusions: Our results show that intratympanic corticosteroids is an effective therapy for the control of vertiginous crises and hearing loss in patients with Meniere´s disease.
- Referencias
- Cómo citar
- Del mismo autor
- Métricas
Pérez H, López J, Morales C, Fernández NP. Enfermedad de Ménière: desde las ciencias básicas hacia la medicina clínica. Enferm Ménière desde las ciencias básicas hacia la Med clínica [Internet]. 2009;85–92. Available from: https://seorl.net/PDF/ponencias%20oficiales/2009%20Enfermedad%20de%20Meniere%20desde%20las%20ciencias%20b%C3%A1sicas%20hasta%20la%20medicina%20cl%C3%ADnica.pdf
Howard S Moskowitz, MD, PhD, Elizabeth A Dinces M. Enfermedad de Meniere: evaluación, diagnóstico y tratamiento. UpToDate. 2020;(Dm):1–29.
Morales Angulo C, Gómez Castellanos R, García Mantilla J, Bezos Capelastegui J, Carrera F. Epidemiología de la enfermedad de Menière en Cantabria. Acta Otorrinolaringol Esp. 2003;54:601–5.
López Escámez JA, Carey J, Chung WH, Goebel JA, Magnusson M, Mandalà M et al. Criterios diagnósticos de enfermedad de Ménière. Documento de consenso de la Bárány Society, la Japan Society for Equilibrium Research, la European Academy of Otology and Neurotology (EAONO). Acta Otorrinolaringol Esp. 2016;67(1):1-7.
Suarez Nieto C, Gil-Carcedo Garcia LM, Marco Algarra J, Medina JE, Ortega del Álamo P, Trinidad Pinedo J. Tratado de Otorrinolaringología y Cirugía de Cabeza y Cuello. In: Panamericana, editor. 2.a. 2007. p. 1841–62.
Attrache NA Al, Krstulovic C, Guillen VP, Pérez CM, Garrigues HP. Response over time of vertigo spells to intratympanic dexamethasone treatment in meniere’s disease patients. J Int Adv Otol. 2016;12(1):92–7.
Herraiz C, Plaza G, Aparicio JM, Gallego I, Marcos S, Ruiz C. Transtympanic steroids for ménière’s disease. Otol Neurotol. 2010;31(1):162–7.
Casani A Pietro, Piaggi P, Cerchiai N, Seccia V, Franceschini SS, Dallan I. Intratympanic treatment of intractable unilateral ménière disease: Gentamicin or dexamethasone? A randomized controlled trial. Otolaryngol - Head Neck Surg. 2012;146(3):430–7.
Lambert PR, Carey J, Mikulec AA, LeBel C. Intratympanic sustained-exposure dexamethasone thermosensitive gel for symptoms of ménière’s disease: Randomized phase 2b safety and efficacy trial. Otol Neurotol. 2016;37(10):1669–76.
Saeed BMN, Tawalbeh M, Al-Omari AF. Intratympanic dexamethasone in Meniere’s disease. Egypt J Ear, Nose, Throat Allied Sci. 2016;17(2):63–9.
Paragache G, Panda NK, Ragunathan M, Sridhara. Intratympanic dexamethasone application in Meniere’s disease - Is it superior to conventional therapy? Indian J Otolaryngol Head Neck Surg. 2005;57(1):21–3.
Silverstein H, Isaacson JE, Olds MJ, Todd Rowan P, Rosenberg S. Dexamethasone inner ear perfusion for the treatment of Meniere’s disease: A prospective, randomized, double-blind, crossover trial. Am J Otol. 1998;19:196–201.
Garduño-Anaya MA, De Toledo HC, Hinojosa-González R, Pane-Pianese C, Ríos-Castañeda LC. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière’s disease: A two-year prospective, placebo-controlled, double-blind, randomized trial. Otolaryngol - Head Neck Surg. 2005;133(2):285–94.
Howard S Moskowitz, MD, PhD, Elizabeth A Dinces M. Enfermedad de Meniere: evaluación, diagnóstico y tratamiento. UpToDate. 2020;(Dm):1–29.
Morales Angulo C, Gómez Castellanos R, García Mantilla J, Bezos Capelastegui J, Carrera F. Epidemiología de la enfermedad de Menière en Cantabria. Acta Otorrinolaringol Esp. 2003;54:601–5.
López Escámez JA, Carey J, Chung WH, Goebel JA, Magnusson M, Mandalà M et al. Criterios diagnósticos de enfermedad de Ménière. Documento de consenso de la Bárány Society, la Japan Society for Equilibrium Research, la European Academy of Otology and Neurotology (EAONO). Acta Otorrinolaringol Esp. 2016;67(1):1-7.
Suarez Nieto C, Gil-Carcedo Garcia LM, Marco Algarra J, Medina JE, Ortega del Álamo P, Trinidad Pinedo J. Tratado de Otorrinolaringología y Cirugía de Cabeza y Cuello. In: Panamericana, editor. 2.a. 2007. p. 1841–62.
Attrache NA Al, Krstulovic C, Guillen VP, Pérez CM, Garrigues HP. Response over time of vertigo spells to intratympanic dexamethasone treatment in meniere’s disease patients. J Int Adv Otol. 2016;12(1):92–7.
Herraiz C, Plaza G, Aparicio JM, Gallego I, Marcos S, Ruiz C. Transtympanic steroids for ménière’s disease. Otol Neurotol. 2010;31(1):162–7.
Casani A Pietro, Piaggi P, Cerchiai N, Seccia V, Franceschini SS, Dallan I. Intratympanic treatment of intractable unilateral ménière disease: Gentamicin or dexamethasone? A randomized controlled trial. Otolaryngol - Head Neck Surg. 2012;146(3):430–7.
Lambert PR, Carey J, Mikulec AA, LeBel C. Intratympanic sustained-exposure dexamethasone thermosensitive gel for symptoms of ménière’s disease: Randomized phase 2b safety and efficacy trial. Otol Neurotol. 2016;37(10):1669–76.
Saeed BMN, Tawalbeh M, Al-Omari AF. Intratympanic dexamethasone in Meniere’s disease. Egypt J Ear, Nose, Throat Allied Sci. 2016;17(2):63–9.
Paragache G, Panda NK, Ragunathan M, Sridhara. Intratympanic dexamethasone application in Meniere’s disease - Is it superior to conventional therapy? Indian J Otolaryngol Head Neck Surg. 2005;57(1):21–3.
Silverstein H, Isaacson JE, Olds MJ, Todd Rowan P, Rosenberg S. Dexamethasone inner ear perfusion for the treatment of Meniere’s disease: A prospective, randomized, double-blind, crossover trial. Am J Otol. 1998;19:196–201.
Garduño-Anaya MA, De Toledo HC, Hinojosa-González R, Pane-Pianese C, Ríos-Castañeda LC. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière’s disease: A two-year prospective, placebo-controlled, double-blind, randomized trial. Otolaryngol - Head Neck Surg. 2005;133(2):285–94.
González-Zapatero, J. M. ., Fernández-Nava, M. J., Ferreira-Cendón, S., González-Sánchez, E., Serradilla-López, J. M., & Batuecas-Caletrío, Ángel. (2022). Efectivity of intratympanic corticosteroids in the treatment of Meniere´s disease- Cohort study. Revista ORL, 13(3), e27951. https://doi.org/10.14201/orl.27951
Most read articles by the same author(s)
- Irene Bermúdez-Castellanos, Cristina Nicole Almeida-Ayerve, Susana Marcos-Alonso, Juan Carlos Del Pozo-De Dios, Jorge Martin-Polo, Ángel Batuecas-Caletrío, Impact of small vessel disease on instability in the elderly. Cross-sectional descriptive study , Revista ORL: Vol. 13 No. 4 (2022)
- Irene Fernández-Bardón, Sofía Pacheco-López, Paula Peña-Navarro, Susana Marcos-Alonso, Enrique Calvo-Boizas, Ángel Batuecas-Caletrio, Benign paroxystic positional vértigo and Menière’s disease: a retrospective análisis , Revista ORL: Vol. 14 No. 2 (2023)
- Cristina Villaoslada Fuentes, María José Fernández-Nava, Sofía Ferreira Cendón, Rosana Villaoslada Fuentes, Hortensia Sánchez Gómez, Ángel Batuecas Caletrío, Hearing loss after intratympanic gentamicin in Ménière's disease. Retrospective study , Revista ORL: Vol. 12 No. 3 (2021)
- Guillermo Estébanez-Peláez, José Luis Pardal-Refoyo, Enrique González-Sánchez, Sofía Ferreira-Cendón, Intraoperative neuromonitoring and postoperative bilateral laryngeal paralysis in total thyroidectomy. Systematic review and meta-analysis , Revista ORL: Vol. 13 No. 4 (2022)
- Maria Corbacho-Zaldívar, Enrique González-Sánchez, Systematic review of the prevalence of infectious serology in peripheral facial paralysis , Revista ORL: Vol. 12 No. 2 (2021)
- Cristina Nicole Almeida-Ayerve, Susana Marcos-Alonso, María José Fernández-Nava, Paula Peña-Navarro, Chiara Monópoli-Roca, Enrique Calvo-Boizas, Bilateral Neurosensorial Hearing Loss in postCovid Child , Revista ORL: Vol. 13 No. S2 (2022): XXVIII Congreso de la Sociedad Otorrinolaringológica de Castilla y León, Cantabria y La Rioja Valladolid 2, 3 y 4 de junio de 2022
- Gianni Mercy García-Núñez, Jorge De Ramos-suárez, Francisco Gabriel Castillo-Varela, Rosana Villaoslada-Fuentes, Sofía Ferreira-Cendón, Santiago Santa Cruz-ruiz, Ángel Batuecas-Caletrio, Influencia de la pérdida auditiva en la enfermedad de Ménière con pérdida para sonidos agudos , Revista ORL: SORIA 2019
- Sofía Pacheco-López, Marta Santa Cruz-González, Paula Peña-Navarro, María José Fernández-Nava, Ángel Batuecas-Caletrio, Santiago Santa Cruz-Ruiz, Results of Nurotron Cochlear Implant in Elderly Population , Revista ORL: Vol. 13 No. S2 (2022): XXVIII Congreso de la Sociedad Otorrinolaringológica de Castilla y León, Cantabria y La Rioja Valladolid 2, 3 y 4 de junio de 2022
- José Ignacio Benito-Orejas, Ángel Batuecas-Caletrío, Practical guideline for benign paroxysmal positional vertigo: collaboration as way to improve the assistance , Revista ORL: Vol. 8 No. 3 (2017)
- María José Fernández-Nava, Sofía Ferreira Cendón, Sara Alonso de la Iglesia, María de las Mercedes Cecilio Rivas, Ana Belén Alonso San Eloy, Ángel Batuecas Caletrío, Stability limits in different posturography patterns. Cohort study. , Revista ORL: Vol. 13 No. 4 (2022)
Downloads
Download data is not yet available.
+
−